Page last updated: 2024-09-04

tipifarnib and geraniol

tipifarnib has been researched along with geraniol in 2 studies

Compound Research Comparison

Studies
(tipifarnib)
Trials
(tipifarnib)
Recent Studies (post-2010)
(tipifarnib)
Studies
(geraniol)
Trials
(geraniol)
Recent Studies (post-2010) (geraniol)
30992947099437

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crovella, S; De Leo, L; Decorti, G; Marcuzzi, A; Pontillo, A; Tommasini, A1
Crovella, S; Kleiner, G; Marcuzzi, A; Monasta, L; Piscianz, E; Tricarico, PM; Zanin, V1

Other Studies

2 other study(ies) available for tipifarnib and geraniol

ArticleYear
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.
    Pediatric research, 2011, Volume: 70, Issue:1

    Topics: Acyclic Monoterpenes; Alendronate; Animals; Anti-Inflammatory Agents; Cell Line; Child; Child, Preschool; Cholesterol; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Inflammation Mediators; Lovastatin; Male; Mevalonate Kinase Deficiency; Mice; Monocytes; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Polyenes; Polyisoprenyl Phosphates; Polyunsaturated Alkamides; Pyridines; Quinolones; Terpenes

2011
Temperature and drug treatments in mevalonate kinase deficiency: an ex vivo study.
    BioMed research international, 2013, Volume: 2013

    Topics: Acyclic Monoterpenes; Anti-Inflammatory Agents; Apoptosis; Biosynthetic Pathways; Carrier Proteins; Child; Cytokines; Female; Humans; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Male; Mevalonate Kinase Deficiency; Mevalonic Acid; NLR Family, Pyrin Domain-Containing 3 Protein; Quinolones; Temperature; Terpenes

2013